DE60116655D1 - Carbamatderivate, verfahren zu deren herstellung und deren verwendung - Google Patents

Carbamatderivate, verfahren zu deren herstellung und deren verwendung

Info

Publication number
DE60116655D1
DE60116655D1 DE60116655T DE60116655T DE60116655D1 DE 60116655 D1 DE60116655 D1 DE 60116655D1 DE 60116655 T DE60116655 T DE 60116655T DE 60116655 T DE60116655 T DE 60116655T DE 60116655 D1 DE60116655 D1 DE 60116655D1
Authority
DE
Germany
Prior art keywords
optionally substituted
substituted
derivatives
chem
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60116655T
Other languages
English (en)
Other versions
DE60116655T2 (de
Inventor
Fumio Itoh
Hiroshi Banno
Masaki Kawamura
Shuji Kitamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda Pharmaceutical Co Ltd
Original Assignee
Takeda Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Pharmaceutical Co Ltd filed Critical Takeda Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60116655D1 publication Critical patent/DE60116655D1/de
Publication of DE60116655T2 publication Critical patent/DE60116655T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60116655T 2000-11-08 2001-11-08 Carbamatderivate, verfahren zu deren herstellung und deren verwendung Expired - Fee Related DE60116655T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000341067 2000-11-08
JP2000341067 2000-11-08
PCT/JP2001/009759 WO2002038560A1 (fr) 2000-11-08 2001-11-08 Derives de carbamate, ainsi que procede de production et utilisation de ceux-ci

Publications (2)

Publication Number Publication Date
DE60116655D1 true DE60116655D1 (de) 2006-04-06
DE60116655T2 DE60116655T2 (de) 2006-11-16

Family

ID=18815863

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60116655T Expired - Fee Related DE60116655T2 (de) 2000-11-08 2001-11-08 Carbamatderivate, verfahren zu deren herstellung und deren verwendung

Country Status (7)

Country Link
US (1) US7109200B2 (de)
EP (1) EP1340753B1 (de)
AT (1) ATE315561T1 (de)
AU (1) AU2002214266A1 (de)
CA (1) CA2428123A1 (de)
DE (1) DE60116655T2 (de)
WO (1) WO2002038560A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080200431A1 (en) * 2005-07-08 2008-08-21 Astrazeneca Ab Heterocyclic Sulfonamide Derivatives as Inhibitors of Factor Xa
CN101218227A (zh) * 2005-07-08 2008-07-09 阿斯利康(瑞典)有限公司 作为因子Xa的抑制剂的杂环磺酰胺衍生物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612353A (en) * 1995-06-07 1997-03-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds
EP1048652A4 (de) * 1997-12-26 2001-05-09 Mochida Pharm Co Ltd Aromatische verbindungen mit einer zyklischen aminogruppe oder ihre salze
SK11082000A3 (sk) 1998-01-27 2001-01-18 Aventis Pharmaceuticals Products Inc. Substituované oxoazaheterocyklické inhibítory faktora xa, farmaceutický prostriedok s ich obsahom a ich použitie
EP1054005A4 (de) * 1998-02-05 2003-02-05 Takeda Chemical Industries Ltd Sulfonamidderivate, verfahren zu ihrer herstellung und ihre verwendung
FR2781062B1 (fr) * 1998-07-09 2002-07-12 Saint Gobain Vitrage Vitrage a proprietes optiques et/ou energetiques electrocommandables
ATE325114T1 (de) * 1999-06-22 2006-06-15 Takeda Pharmaceutical Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
EP1340753A1 (de) 2003-09-03
AU2002214266A1 (en) 2002-05-21
DE60116655T2 (de) 2006-11-16
WO2002038560A1 (fr) 2002-05-16
ATE315561T1 (de) 2006-02-15
EP1340753B1 (de) 2006-01-11
US7109200B2 (en) 2006-09-19
CA2428123A1 (en) 2002-05-16
EP1340753A4 (de) 2004-01-14
US20040038986A1 (en) 2004-02-26

Similar Documents

Publication Publication Date Title
ATE368655T1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
DK1260512T3 (da) Hidtil ukendte, cykliske amidderivater
DE60142934D1 (de) Pharmazeutische dopamin-glykokonjugat-zusammensetzungen und verfahren zu deren herstellung
EA200100090A2 (ru) Новые пиперидин-4-сульфонамидные производные, способ их получения и содержащие их фармацевтические композиции
ATA49688A (de) Neue pyridazinonderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE69119135T2 (de) Substituierte Pyridinsulfonamidverbindungen, diese enthaltende herbizide Zusammensetzungen und Verfahren zu ihrer Herstellung
ATE325790T1 (de) Harnstoff-verbindungen, ein verfahren zu deren herstellung und ihre verwendung
DE60116655D1 (de) Carbamatderivate, verfahren zu deren herstellung und deren verwendung
MXPA01013148A (es) Nuevos derivados de amonio cuaternario, metodo para la preparacion de los mismos y uso farmaceutico.
DE69926776D1 (de) Quinalozinon-derivate
ATE279191T1 (de) Trizyklische dihydrobenzofurane, verfahren zu deren herstellung und mittel
ATE365162T1 (de) Tetrahydropyridyl-alkyl-heterozykle, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten
ATE309198T1 (de) Fungizide mit einer fluorovinyl-oder fluoropropenyloxyphenyloxim-einheit und ein verfahren zu ihrer herstellung.
MXPA05009338A (es) 7-alquenilamino-triazolopirimidinas, procedimientos para su obtencion y el uso de las mismas para controlar hongos nocivos, asi como productos que los contienen.
ATE384717T1 (de) Stereoisomere indolderivate, verfahren zu ihrer herstellung und ihre verwendung
DE69837628D1 (de) Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel
BR9812928A (pt) Novos derivados de 3-oxo-(2h) -1,2,4-triazina, processo de preparação de compostos quìmicos, e, composição farmacêutica
ATE264314T1 (de) Benzoxazol-derivate, verfahren zu ihrer herstellung und herbizide
DE69626624D1 (de) Medikamente gegen trhombocytopenie
ATE493988T1 (de) Pyrimidinderivate enthaltendes medikament
ATE138068T1 (de) 1,2,4-triazolo(1,5-a>pyrimidinderivate, verfahren zu ihrer herstellung, diese enthaltende arzneimittel und ihre verwendung
ATE253048T1 (de) Verfahren zur herstellung von piperidincarbonsäureamiden
TH20305A (th) อนุพันธ์ 3-(5-เททราโซลิล-เบนซิล) อะมิโนพิเพอริดีน
TH54292A (th) กรรมวิธีสำหรับการเตรียม n-แอริล-แอนธรานิลิคแอซิด และอนุพันธ์ของสารเหล่านั้น
TH54292B (th) กรรมวิธีสำหรับการเตรียม n-แอริล-แอนธรานิลิคแอซิด และอนุพันธ์ของสารเหล่านั้น

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee